Powder specific active dispersion for generation of pharmaceutical aerosols

International Journal of Pharmaceutics

Volumn 327, Issue 1-2, 2006, Pages 65-72

  Crowder, T ^a   Hickey, A ^a,b  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Active dry powder inhaler; Inhalation drug delivery; Powder avalanching; Powder flow; Vertical vibration

Indexed keywords

EXCIPIENT; LACTOSE; MALTODEXTRIN; SALBUTAMOL SULFATE;

AEROSOL; ARTICLE; DISPERSION; DRUG DELIVERY SYSTEM; DRY POWDER; ENERGY YIELD; FREQUENCY ANALYSIS; PHYSICAL PHASE; POWDER INHALER; PRIORITY JOURNAL; REPRODUCIBILITY; VIBRATION;

AEROSOLS; ALBUTEROL; BRONCHODILATOR AGENTS; EXCIPIENTS; LACTOSE; NEBULIZERS AND VAPORIZERS; POLYSACCHARIDES; POWDERS;

EID: 33750525303     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2006.07.050     Document Type: Article

References (26)

1. Alexander A.W., Chaudhuri B., Faqih A., Muzzio F.J., Davies C., and Tomassone M.S. Avalanching flow of cohesive powders. Powder Technol. 164 (2006) 13-21
2. Aranson I.S., Blair D., Kwok W.K., Karapetrov G., Welp U., Crabtree G.W., and Vinokur V.M. Controlled dynamics of interfaces in a vibrated granular layer. Phys. Rev. Lett. 82 (1999) 731-734
3. Atkins P.J., and Crowder T.M. The design and development of inhalation drug delivery systems. In: Hickey A.J. (Ed). Pharmaceutical Inhalation Aerosol Technology (2004), Marcel Dekker, New York 279-309
4. Auty R.M., Brown K., Neale M.G., and Snashall P.D. Respiratory tract deposition of sodium cromoglycate is highly dependent upon technique of inhalation using the spinhaler. Brit. J. Dis. Chest 81 (1987) 371-380
5. Baumann G., Jánosi I.M., and Wolf D.E. Surface properties and flow of granular material in a two-dimensional rotating-drum model. Phys. Rev. E 51 (1995) 1879-1888
6. Boateng A.A. Boundary layer modeling of granular flow in the transverse plane of a partially filled rotating cylinder. Int. J. Multiphase Flow 24 (1998) 499-521
7. Castellanos A., Valverde J.M., Pérez A.T., Ramos A., and Watson P.K. Flow regimes in fine cohesive powders. Phys. Rev. Lett. 82 (1999) 1156-1159
8. CDER. Guidance for Industry: Metered Dose Inhaler (MDI) and Dry Powder Inhaler (DPI) Drug Products (1998), CDER, Rockville, MD
9. Clark A.R., and Hollingworth A.M. The relationship between powder inhaler resistance and peak inspiratory conditions in healthy volunteers-implications for in vitro testing. J. Aerosol Med. 6 (1993) 99-110
10. Concessio N.M., Van Oort M., Knowles M.R., and Hickey A.J. Pharmaceutical dry powder aerosols: correlation of powder properties with dose delivery and implications for pharmacodynamic effect. Pharm. Res. 16 (1999) 828-834
11. Crowder, T.M., Kraabel, S., Boyce, C., 2003. Rapid formulation independent DPI development. In: Drug Delivery to the Lungs, vol. XIV. London, UK.
12. Crowder T.M., Louey M.D., Sethuraman V.V., Smyth H.D.C., and Hickey A.J. An odyssey in inhaler formulations and design. Pharm. Tech. 25 (2001) 99-113
13. Crowder T.M., Sethuraman V., Fields T.B., and Hickey A.J. Signal processing and analysis applied to powder behavior in a rotating drum. Part. Part. Syst. Charact. 16 (1999) 191-196
14. Duran J. Ripples in tapped or blown powder. Phys. Rev. Lett. 84 (2000) 5126-5129
15. Hickey A.J., and Concessio N.M. Descriptors of irregular particle morphology and powder properties. Adv. Drug Deliver. Rev. 26 (1997) 29-40
16. Hickey A.J., Concessio N.M., Van Oort M.M., and Platz R.M. Factors influencing the dispersion of dry powders as aerosols. Pharm. Tech. 18 (1994) 58-64
17. Hickey A.J., and Dunbar C.A. A new millennium for inhaler technology. Pharm. Tech. 21 (1997) 116-125
18. Hindle M., and Byron P.R. Dose emissions from marketed dry powder inhalers. Int. J. Pharm. 116 (1995) 169-177
19. Melo F., Umbanhowar P.B., and Swinney H.L. Transition to parametric wave patterns in a vertically oscillated granular layer. Phys. Rev. Lett. 72 (1994) 172-175
20. Melo F., Umbanhowar P.B., and Swinney H.L. Hexagons, kinks, and disorder in oscillated granular layers. Phys. Rev. Lett. 75 (1995) 3838-3841
21. Montreal Protocol, 1987. Montreal protocol on substances that deplete the ozone layer, 26 ILM 1541.
22. Morales-Gamboa E., Lomnitz-Adler J., Romero-Rochín V., Chicharro-Serra R., and Peralta-Fabi R. Two-dimensional avalanches as stochastic markov processes. Phys. Rev. E 47 (1993) R2229-R2232
23. Pak H.K., and Behringer R.P. Surface waves in vertically vibrated granular materials. Phys. Rev. Lett. 71 (1993) 1832-1835
24. Peart J., and Clarke M.J. New developments in dry powder inhaler technology. Am. Pharm. Rev. 4 (2001) 37-45
25. Prime D., Atkins P.J., Slater A., and Sumby B. Review of dry powder inhalers. Adv. Drug Deliver. Rev. 26 (1997) 51-58
26. US Food and Drug Administration. Use of Ozone-depleting Substances; Removal of Essential-use Designations (2005), US Food and Drug Administration. http://www.fda.gov/OHRMS/DOCKETS/98fr/03p-0029-nfr0001.pdf